David Berz
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
Papers in
- Oncology 18
- Cancer Immunotherapy and Biomarkers 10
- Colorectal Cancer Treatments and Studies 2
- Cancer-related Molecular Pathways 2
-
- Lung Cancer Treatments and Mutations 14
- Lung Cancer Diagnosis and Treatment 3
- Advanced Breast Cancer Therapies 2
- Co-authors
- Gerald A. Colvin (12 shared papers)Peter J. Quesenberry (6 shared papers)Eric S. Winer (4 shared papers)Elise M. McCormack (5 shared papers)Mark S. Dooner (3 shared papers)Douglas C. Hixson (2 shared papers)Bharat Ramratnam (2 shared papers)Harold J. Wanebo (4 shared papers)
- Journals
- Annals of Oncology (8 papers)Journal of Thoracic Oncology (5 papers)Blood (3 papers)Journal of Clinical Oncology (3 papers)Experimental Hematology (2 papers)
- Partner nations
- United StatesGermanyJapan
In The Last Decade
David Berz
56 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 78
- Cancer Research 258
- Hematology 190
- Pulmonary and Respiratory Medicine 357
- Oncology 209
- Genetics 72
Countries citing papers authored by David Berz
This map shows the geographic impact of David Berz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Berz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Berz more than expected).
Fields of papers citing papers by David Berz
This network shows the impact of papers produced by David Berz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Berz. The network helps show where David Berz may publish in the future.
Co-authors
The 25 scholars most cited alongside David Berz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 258 | |
| 2 | 2007 | 207 | |
| 3 | 2010 | 184 | |
| 4 | 2020 | 127 | |
| 5 | 2009 | 62 | |
| 6 | 2017 | 50 | |
| 7 | 2020 | 47 | |
| 8 | 2008 | 45 | |
| 9 | 2023 | 38 | |
| 10 | 2023 | 29 | |
| 11 | 2011 | 28 | |
| 12 | 2011 | 24 | |
| 13 | 2017 | 24 | |
| 14 | 2018 | 24 | |
| 15 | 2025 | 24 | |
| 16 | 2013 | 22 | |
| 17 | 2013 | 21 | |
| 18 | 2011 | 19 | |
| 19 | 2021 | 19 | |
| 20 | 2015 | 18 |
About David Berz
David Berz is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Hematology, Pathology and Forensic Medicine and Cancer Research, having authored 58 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (14 papers), Cancer Immunotherapy and Biomarkers (10 papers), Hematopoietic Stem Cell Transplantation (5 papers), Lung Cancer Diagnosis and Treatment (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Advanced Breast Cancer Therapies (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Cancer Research (258 citations), Hematology (190 citations), Pulmonary and Respiratory Medicine (357 citations), Oncology (209 citations) and Genetics (72 citations). David Berz has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Gerald A. Colvin, Peter J. Quesenberry, Eric S. Winer, Elise M. McCormack, Mark S. Dooner, Douglas C. Hixson, Bharat Ramratnam, Harold J. Wanebo, Jason M. Aliotta and Carol A. Ayala. Their work appears in journals such as Annals of Oncology, Journal of Thoracic Oncology, Blood, Journal of Clinical Oncology and Experimental Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.